Last update 20 Mar 2025

BCMA CAR-T cell therapy(Chongqing Precision Biotechnology Co., Ltd.)

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms-
Target
BCMA
Action
modulators
Mechanism
BCMA modulators(B-cell maturation protein modulators), Immunologic cytotoxicity, T lymphocyte replacements
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [1]
Active Indication
Plasma Cell LeukemiaRefractory Multiple MyelomaRelapse multiple myeloma
Inactive Indication-
Originator Organization
Chongqing Precision Biotechnology Co., Ltd.Chongqing Precision Biotechnology Co., Ltd.
Active Organization
Chongqing Precision Biotechnology Co., Ltd.Chongqing Precision Biotechnology Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with BCMA CAR-T cell therapy(Chongqing Precision Biotechnology Co., Ltd.)
NCT04776330
/ RecruitingPhase 1/2
Study Evaluating Safety and Efficacy of BCMA-Targeted Prime CAR-T Cell in Patients with Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease
NCT04272151
/ RecruitingPhase 1/2
Safety and Efficacy of BCMA-Targeted CAR-T Therapy for Relapsed/Refractory Multiple Myeloma
NCT04271644
/ RecruitingPhase 1/2
BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease
100 Clinical Results associated with BCMA CAR-T cell therapy(Chongqing Precision Biotechnology Co., Ltd.)
Login to view more data
100 Translational Medicine associated with BCMA CAR-T cell therapy(Chongqing Precision Biotechnology Co., Ltd.)
Login to view more data
100 Patents (Medical) associated with BCMA CAR-T cell therapy(Chongqing Precision Biotechnology Co., Ltd.)
Login to view more data
100 Deals associated with BCMA CAR-T cell therapy(Chongqing Precision Biotechnology Co., Ltd.)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Plasma Cell LeukemiaPhase 2
China
Chongqing Precision Biotechnology Co., Ltd.Chongqing Precision Biotechnology Co., Ltd.
01 Apr 2019
Refractory Multiple MyelomaPhase 2
China
Chongqing Precision Biotechnology Co., Ltd.Chongqing Precision Biotechnology Co., Ltd.
01 Apr 2019
Relapse multiple myelomaPhase 2
China
Chongqing Precision Biotechnology Co., Ltd.Chongqing Precision Biotechnology Co., Ltd.
01 Apr 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free